Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -44.9292.58-57.38-14.14442.89

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is -44.92 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14
Mar2021442.89

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14
Negative
Mar2021 442.89 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹872.3 Cr -1.4% -4.8% -35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-1.4%

-4.8%

-35.9%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses